Skip to main content
SpringerLink
Log in

Pro & Kontra

Metformin bei Typ-2-Diabetes: Therapie der ersten Wahl?

  • Fortbildung
  • Schwerpunkt Diabetes
  • Published:
CardioVasc Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Mit freundlicher Genehmigung von Thieme aus [4]

Author information

Authors and Affiliations

  1. Univ. Tübingen\/Stv. ärztl. Direktor, Med. Klinik IV\/Klinik f. Diabetologie, Endokrinologie, Otfried-Müller-Straße 10, 72076, Tübingen, Germany

    Baptist Gallwitz

  2. Universitätsklinikum Aachen\/AÖR, Dir. d. Klinik f. Kardiologie\/Pneumologie\/Intern. Intensivmedizin, Pauwelsstraße 30, 52074, Aachen, Germany

    Nikolaus Marx

Authors
  1. Baptist Gallwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nikolaus Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baptist Gallwitz.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gallwitz, B., Marx, N. Metformin bei Typ-2-Diabetes: Therapie der ersten Wahl?. CV 21, 27–30 (2021). https://doi.org/10.1007/s15027-021-3503-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-021-3503-7

Search

Navigation